Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C. Fakih MG, Salvatore L, Esaki T, Modest DP, et al. N Engl J Med 2023 Oct 22. doi: 10.1056/NEJMoa2308795.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fakih MG, Salvatore L, Esaki T, Modest DP, et al. Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C. N Engl J Med 2023 Oct 22. doi: 10.1056/NEJMoa2308795.
PMID: 37870968